Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.92
Delayed Data
As of Sep 30
 -0.01 / -0.52%
Today’s Change
1.23
Today|||52-Week Range
2.31
-1.03%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.93
Today’s open1.94
Day’s range1.88 - 1.99
Volume66,800
Average volume (3 months)53,291
Market cap$74.6M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc+0.40+9.85%
APDNApplied DNA Sciences...-0.02-0.65%
INFIInfinity Pharmaceuti...+0.05+3.31%
ATNMActinium Pharmaceuti...+0.02+1.50%
Data as of 4:01pm ET, 09/30/2016

Financials

Next reporting dateNovember 4, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts

Search for Jobs